MiR-3473b can regulate the secretion of pro-inflammatory mediators by targeting TREM2/ULK1 expression, thereby modulating the role of autophagy in the pathogenesis of Parkinson’s disease (PD) inflammation (Lv et al., 2021). Here, ULK1 is linked to Parkinson disease.